Govt to buy 260,000 tonnes of fuel on emergency basis amid Middle East war

Dhaka, March 31 -- The government will procure an additional 260,000 tonnes of fuel to meet emergency energy demands triggered by the ongoing conflict in the Middle East. The procurement includes 100... Read More

Vaibhav Sooryavanshi : వైభవ్​ సూర్యవంశీ.. పిల్లోడు కాదు పిడుగు- 15ఏళ్లకే కళ్లు చెదిరే నెట్​ వర్త్​!

భారతదేశం, మార్చి 31 -- వైభవ్​ సూర్యవంశీ.. గత కొంతకాలంగా, భారత క్రికెట్​ ప్రపంచంలో మారుమోగిపోతున్న పేరు ఇది! ఈ 15ఏళ్ల యువ క్రికెటర్​ సృష్టిస్తున్న సంచలనాలు అంతా ఇంతా కాదు. అందుకే అందరు వైభవ్​ని "పిల్లో... Read More

Upaban Express engine breaks down in Moulvibazar, train service resumes after 3 hours

Dhaka, March 31 -- The engine of the Sylhet-bound Upaban Express train has caught on fire in Moulvibazar's Kamalganj, disrupting rail communication with Sylhet for three hours. The engine of the trai... Read More

Axis Nifty AAA Bond Plus SDL Apr 2026 50:50 ETF Merger into Axis CRISIL IBX 50:50 Gilt Plus SDL June 2028 Index Fund

Mumbai, March 31 -- Axis Mutual Fund has approved the merger of Axis Nifty AAA Bond Plus SDL Apr 2026 50:50 ETF Merger into Axis CRISIL IBX 50:50 Gilt Plus SDL June 2028 Index Fund, with effect from 3... Read More

Driver shot as car carrying expat 'robbed' on way back from airport in Narayanganj

Dhaka, March 31 -- The driver of a car has been shot and injured as the vehicle carrying a Bangladeshi expatriate returning from Saudi Arabia was allegedly attacked by a gang of robbers in Narayanganj... Read More

Dollar index at 10-month high; Set for a monthly gain of 3%

Mumbai, March 31 -- The US dollar index rallied above 100 mark a 10 month high this morning in Asia amid firm safe haven demand for the greenback on escalating tensions in the Middle East. The US-Isra... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy... Read More

Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, ... Read More

Singapore Clinical Trial: A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3537031 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3537031 in Healthy Participants

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, 2-Part Study to Determine the Effect of Injection Site on the Relative Bioavailability... Read More

Singapore Clinical Trial: A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzumab Tirumotecan, MK-2870) Followed by Carboplatin/Paclitaxel vs Chemotherapy, Both in Combination With Pembrolizumab as Neoadjuvant Therapy for High-Risk, Early-Stage, Triple-Negative Breast Cancer or Hormone Receptor-low Positive/Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT (Sacituzuma... Read More

• ««
• «
• 10252
• 10253
• 10254
• 10255
• 10256
• 10257
• 10258
• 10259
• 10260
• 10261
• »
• »»